Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 9,567.00
-35.00 (-0.36%)
Sep 25, 2026, 3:15 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 2.55 trillion as of September 25, 2026. Its market cap has increased by 60.75% in one year.
Market Cap
2.55T
Enterprise Value
2.52T
Revenue
112.30B
Ranking
n/a
PE Ratio
87.28
Stock Price
9,567.00
ChartMarket Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 2.55T, an increase of 125,355.90%. That is a compound annual growth rate of 35.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 2.55T | 50.48% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.47T |
| Zydus Lifesciences | 1.17T |
| Cipla | 1.12T |
| Laurus Labs | 1.10T |
| Mankind Pharma | 1.02T |
| Aurobindo Pharma | 990.51B |
| Glenmark Pharmaceuticals | 698.45B |
| Alkem Laboratories | 647.74B |